These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 15574782)
1. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Adhami VM; Siddiqui IA; Ahmad N; Gupta S; Mukhtar H Cancer Res; 2004 Dec; 64(23):8715-22. PubMed ID: 15574782 [TBL] [Abstract][Full Text] [Related]
2. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609 [TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action. Harper CE; Patel BB; Wang J; Eltoum IA; Lamartiniere CA Prostate; 2007 Oct; 67(14):1576-89. PubMed ID: 17705241 [TBL] [Abstract][Full Text] [Related]
4. Angiogenesis and prostate cancer: identification of a molecular progression switch. Huss WJ; Hanrahan CF; Barrios RJ; Simons JW; Greenberg NM Cancer Res; 2001 Mar; 61(6):2736-43. PubMed ID: 11289156 [TBL] [Abstract][Full Text] [Related]
5. Apigenin attenuates insulin-like growth factor-I signaling in an autochthonous mouse prostate cancer model. Shukla S; MacLennan GT; Fu P; Gupta S Pharm Res; 2012 Jun; 29(6):1506-17. PubMed ID: 22139534 [TBL] [Abstract][Full Text] [Related]
6. Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells. Banudevi S; Senthilkumar K; Sharmila G; Arunkumar R; Vijayababu MR; Arunakaran J Clin Chim Acta; 2010 Feb; 411(3-4):172-8. PubMed ID: 19913001 [TBL] [Abstract][Full Text] [Related]
7. Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. McLarty J; Bigelow RL; Smith M; Elmajian D; Ankem M; Cardelli JA Cancer Prev Res (Phila); 2009 Jul; 2(7):673-82. PubMed ID: 19542190 [TBL] [Abstract][Full Text] [Related]
8. Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells. Siddiqui IA; Adhami VM; Afaq F; Ahmad N; Mukhtar H J Cell Biochem; 2004 Feb; 91(2):232-42. PubMed ID: 14743383 [TBL] [Abstract][Full Text] [Related]
10. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models. Miyake H; Pollak M; Gleave ME Cancer Res; 2000 Jun; 60(11):3058-64. PubMed ID: 10850457 [TBL] [Abstract][Full Text] [Related]
11. beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts. Goel HL; Breen M; Zhang J; Das I; Aznavoorian-Cheshire S; Greenberg NM; Elgavish A; Languino LR Cancer Res; 2005 Aug; 65(15):6692-700. PubMed ID: 16061650 [TBL] [Abstract][Full Text] [Related]
12. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3. Yin Y; Ni J; Chen M; DiMaggio MA; Guo Y; Yeh S Clin Cancer Res; 2007 Apr; 13(7):2271-80. PubMed ID: 17404112 [TBL] [Abstract][Full Text] [Related]
13. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model. Narayanan BA; Narayanan NK; Pittman B; Reddy BS Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007 [TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis. Liu B; Lee KW; Anzo M; Zhang B; Zi X; Tao Y; Shiry L; Pollak M; Lin S; Cohen P Oncogene; 2007 Mar; 26(12):1811-9. PubMed ID: 16983336 [TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer. Polnaszek N; Kwabi-Addo B; Peterson LE; Ozen M; Greenberg NM; Ortega S; Basilico C; Ittmann M Cancer Res; 2003 Sep; 63(18):5754-60. PubMed ID: 14522896 [TBL] [Abstract][Full Text] [Related]
16. Genistein alters growth factor signaling in transgenic prostate model (TRAMP). Wang J; Eltoum IE; Lamartiniere CA Mol Cell Endocrinol; 2004 Apr; 219(1-2):171-80. PubMed ID: 15149738 [TBL] [Abstract][Full Text] [Related]
17. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Adhami VM; Malik A; Zaman N; Sarfaraz S; Siddiqui IA; Syed DN; Afaq F; Pasha FS; Saleem M; Mukhtar H Clin Cancer Res; 2007 Mar; 13(5):1611-9. PubMed ID: 17332308 [TBL] [Abstract][Full Text] [Related]
18. Phellodendron amurense bark extract prevents progression of prostate tumors in transgenic adenocarcinoma of mouse prostate: potential for prostate cancer management. Ghosh R; Graham H; Rivas P; Tan XJ; Crosby K; Bhaskaran S; Schoolfield J; Banu J; Fernandes G; Yeh IT; Kumar AP Anticancer Res; 2010 Mar; 30(3):857-65. PubMed ID: 20393007 [TBL] [Abstract][Full Text] [Related]
19. Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase. Gupta S; Ahmad N; Mohan RR; Husain MM; Mukhtar H Cancer Res; 1999 May; 59(9):2115-20. PubMed ID: 10232597 [TBL] [Abstract][Full Text] [Related]